Experts Call for a More Patient-Focused Approach to Prior Authorization

On the first full day of conference activity at AMCP 2023, a pair of pharmacists examined the current process for making prior authorization (PA) decisions by focusing their lens on the need for a more patient-focused approach to this often confusing, cumbersome, and drawn-out process. Inclusion and exclusion criteria are the current standard for most PA decisions, but stakeholders may want to start placing greater emphasis on the potential of incorporating baseline and outcomes data from clinical trials into PA criteria.